Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies (Englisch)
- Neue Suche nach: Igweokpala, Samuel
- Neue Suche nach: Sule, Naheemot Olaoluwa
- Neue Suche nach: Douros, Antonios
- Neue Suche nach: Yu, Oriana H. Y.
- Neue Suche nach: Filion, Kristian B.
- Neue Suche nach: Igweokpala, Samuel
- Neue Suche nach: Sule, Naheemot Olaoluwa
- Neue Suche nach: Douros, Antonios
- Neue Suche nach: Yu, Oriana H. Y.
- Neue Suche nach: Filion, Kristian B.
In:
Diabetes, Obesity and Metabolism
;
26
, 2
;
721-731
;
2024
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
-
Beteiligte:Igweokpala, Samuel ( Autor:in ) / Sule, Naheemot Olaoluwa ( Autor:in ) / Douros, Antonios ( Autor:in ) / Yu, Oriana H. Y. ( Autor:in ) / Filion, Kristian B. ( Autor:in )
-
Erschienen in:Diabetes, Obesity and Metabolism ; 26, 2 ; 721-731
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.02.2024
-
Format / Umfang:11 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 26, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 405
-
Diabetes, Obesity and Metabolism| 2024
- 407
-
Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic optionsTack, Wouter / De Cock, Anne‐Marie / Dirinck, Eveline Lia / Bastijns, Sophie / Ariën, Femke / Perkisas, Stany et al. | 2024
- 417
-
Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetesSolis‐Herrera, Carolina / Triplitt, Curtis et al. | 2024
- 431
-
Metabolically healthy obese individuals are still at high risk for diabetes: Application of the marginal structural modelLee, Hye Ah / Park, Hyesook et al. | 2024
- 441
-
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysisKuate Defo, Alvin / Bakula, Veselko / Pisaturo, Alessandro / Labos, Christopher / Wing, Simon S. / Daskalopoulou, Stella S. et al. | 2024
- 463
-
5‐Year simulation of diabetes‐related complications in people treated with tirzepatide or semaglutide versus insulin glargineNiu, Shu / Alkhuzam, Khalid A. / Guan, Dawei / Jiao, Tianze / Shi, Lizheng / Fonseca, Vivian / Laiteerapong, Neda / Ali, Mohammed K. / Schatz, Desmond A. / Guo, Jingchuan et al. | 2024
- 473
-
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trialsPatel, Hiren / Khunti, Kamlesh / Rodbard, Helena W. / Bajaj, Harpreet S. / Bray, Ross / Kindracki, Zbigniew / Rodríguez, Ángel et al. | 2024
- 482
-
Metabolic syndrome, genetic susceptibility, and risk of chronic obstructive pulmonary disease: The UK Biobank StudyLi, Shiwen / Zhang, Tingjing / Yang, Honghao / Chang, Qing / Zhao, Yuhong / Chen, Liangkai / Zhao, Li / Xia, Yang et al. | 2024
- 495
-
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta‐analysisDiallo, Alhassane / Villard, Orianne / Carlos‐Bolumbu, Miguel / Renard, Eric / Galtier, Florence et al. | 2024
- 503
-
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trialLandgraf, Wolfgang / Owens, David R. / Frier, Brian M. / Bolli, Geremia B. et al. | 2024
- 512
-
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational studyShabnam, Sharmin / Abner, Sophia / Gillies, Clare L. / Davies, Melanie J. / Dex, Terry / Khunti, Kamlesh / Webb, David R. / Zaccardi, Francesco / Seidu, Samuel et al. | 2024
- 524
-
In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK BiobankBoonpor, Jirapitcha / Pell, Jill P. / Ho, Frederick K. / Celis‐Morales, Carlos / Gray, Stuart R. et al. | 2024
- 532
-
Greater time spent with HbA1c less than 7.0% with oral semaglutide versus oral comparators: An exploratory analysis of the PIONEER studiesRosenstock, Julio / Cariou, Bertrand / Eliasson, Johanna / Frappin, Guillaume / Kaltoft, Margit S. / Montanya, Eduard / Knop, Filip K. et al. | 2024
- 540
-
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trialShah, Viral N. / Al‐Karadsheh, Amer / Barnes, Cathy / Mandry, Jose / Nakhle, Samer / Wernicke‐Panten, Karin / Kramer, Daniel / Schmider, Wolfgang / Pierre, Suzanne / Teichert, Lenore et al. | 2024
- 548
-
Impact of a dual glucose‐dependent insulinotropic peptide/glucagon‐like peptide‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysisYang, Yucheng / He, Liyun / Liu, Peng / Wang, Jialu / Yang, Na / Li, Ziyi / Ping, Fan / Xu, Lingling / Li, Wei / Zhang, Huabing et al. | 2024
- 557
-
Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristicsHenry, Zoé / Villar Fimbel, Sylvie / Bendelac, Nathalie / Perge, Kevin / Thivolet, Charles et al. | 2024
- 567
-
Weight change in patients with new‐onset type 2 diabetes mellitus and its association with remission: Comprehensive real‐world dataKim, Jinyoung / Kim, Bongseong / Kim, Mee Kyoung / Baek, Ki‐Hyun / Song, Ki‐Ho / Han, Kyungdo / Kwon, Hyuk‐Sang et al. | 2024
- 576
-
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE‐3 studyLieverse, Tom T. G. F. / Puchades, Maria J. / Mulder, Udo D. J. / Provenzano, Michele / Krenning, Guido / Jongs, Niels / Wink, Simon E. / Slart, Riemer H. J. A. / Andreucci, Michele / D'Marco, Luis et al. | 2024
- 583
-
Utility of serum β2‐microglobulin for prediction of kidney outcome among patients with biopsy‐proven diabetic nephropathyUemura, Takayuki / Nishimoto, Masatoshi / Eriguchi, Masahiro / Tamaki, Hiroyuki / Tasaki, Hikari / Furuyama, Riri / Fukata, Fumihiro / Kosugi, Takaaki / Morimoto, Katsuhiko / Matsui, Masaru et al. | 2024
- 592
-
A model‐informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong‐acting dipeptidyl peptidase‐4 inhibitorCui, Cheng / Cao, Fangrui / Kong, Iok Ian / Wu, Qinghe / Li, Fangqiong / Li, Haiyan / Liu, Dongyang et al. | 2024
- 602
-
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age‐period‐cohort analysisLiu, Wenli / Zhang, Duo / Wang, Ruobing / Chen, Junhui / Zhang, Jiaqi / Tao, Di / Liu, Chaonan et al. | 2024
- 611
-
Factors that determine glucose variability, defined by the coefficient of variation in continuous glucose monitoring values, in a Chinese population with type 2 diabetesWen, Xi / Yang, Huijun / Yang, Man / Tao, Wenyu / Chen, Jiaoli / Zhao, Shanshan / Yin, Mingliu / Zhou, Xing / Yang, Ying / Li, Yiping et al. | 2024
- 622
-
Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP+ randomized controlled trialReznik, Yves / Carvalho, Martin / Fendri, Salha / Prevost, Gaetan / Chaillous, Lucy / Riveline, Jean Pierre / Hanaire, Hélène / Dubois, Séverine / Houéto, Patrick / Pasche, Hélène et al. | 2024
- 631
-
Impact of a 4‐week intensive track and field training intervention on glycaemia in adolescents with type 1 diabetes: The ChilDFiT1 studyZimmer, Rebecca T. / Birnbaumer, Philipp / Sternad, Christoph / Zunner, Beate E. M. / Schierbauer, Janis / Fritsch, Maria / Fröhlich‐Reiterer, Elke / Hofmann, Peter / Sourij, Harald / Aberer, Felix et al. | 2024
- 642
-
Effects of CB1R inverse agonist, INV‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b studyCrater, Glenn D. / Lalonde, Karine / Ravenelle, François / Harvey, Michael / Després, Jean‐Pierre et al. | 2024
- 650
-
Non‐alcoholic fatty liver disease is associated with brain function disruption in type 2 diabetes patients without cognitive impairmentLi, Xin / Zhang, Wen / Bi, Yan / Chen, Jiu / Fu, Linqing / Zhang, Zhou / Chen, Qian / Zhang, Xin / Zhu, Zhengyang / Zhang, Bing et al. | 2024
- 663
-
Establishment and validation of a prediction model for gestational diabetesWang, Xia / He, Caidie / Wu, Nian / Tian, Yingkuan / An, Songlin / Chen, Wei / Liu, Xiang / Zhang, Haonan / Xiong, Shimin / Liu, Yijun et al. | 2024
- 673
-
Effect of artificial pancreas system use on glycaemic control among pregnant women with type 1 diabetes mellitus: A meta‐analysis of randomized controlled trialsLei, Mengyun / Chen, Danrui / Ling, Ping / Wang, Chaofan / Yang, Daizhi / Deng, Hongrong / Yang, Xubin / Xu, Wen / Yan, Jinhua et al. | 2024
- 682
-
One‐hour post‐load glucose levels are associated with hepatic steatosis assessed by transient elastographyAndreozzi, Francesco / Mancuso, Elettra / Mazza, Elisa / Mannino, Gaia Chiara / Fiorentino, Teresa Vanessa / Arturi, Franco / Succurro, Elena / Perticone, Maria / Sciacqua, Angela / Montalcini, Tiziana et al. | 2024
- 690
-
Beinaglutide for weight management in Chinese individuals with overweight or obesity: A phase 3 randomized controlled clinical studyChen, Kang / Chen, Li / Shan, Zhongyan / Wang, Guixia / Qu, Shen / Qin, Guijun / Yu, Xuefeng / Xin, Weiquan / Hsieh, Tsung‐han / Mu, Yiming et al. | 2024
- 699
-
Sodium‐glucose co‐transporter‐2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetesFujita, Kaden K. / Ye, Feng / Collister, David / Klarenbach, Scott / Campbell, David J. T. / Chew, Derek S. / Quinn, Amity E. / Ronksley, Paul / Lau, Darren et al. | 2024
- 710
-
Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trialsBantounou, Maria Anna / Sardellis, Panagiotis / Thuemmler, Rosa / Black Boada, Daniel / Kaczmarek, Justyna / Mahmood, Ribeya / Plascevic, Josip / Philip, Sam et al. | 2024
- 721
-
Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studiesIgweokpala, Samuel / Sule, Naheemot Olaoluwa / Douros, Antonios / Yu, Oriana H. Y. / Filion, Kristian B. et al. | 2024
- 732
-
FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathyZhou, Lu / Su, Wating / Wang, Yafeng / Zhang, Yuefu / Xia, Zhongyuan / Lei, Shaoqing et al. | 2024
- 745
-
Improvement of early‐phase insulin secretion is an independent factor for achieving glycaemic control: A pooled analysis of SEED and DAWN studyFeng, Lingge / Chen, Chunxiang / Guo, Quanle / Chen, Li / Yang, Wenying et al. | 2024
- 754
-
Nasal glucagon is safe and effective in children and adolescents with type 1 diabetes: A real‐world prospective cohort studyZucchini, Stefano / Ripoli, Carlo / Cherubini, Valentino / Coccioli, Maria Susanna / Delvecchio, Maurizio / De Marco, Rosaria / Franceschi, Roberto / Gallo, Francesco / Graziani, Vanna / Iafusco, Dario et al. | 2024
- 758
-
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trialSharma, Abhinav / Marques, Pedro / Neuen, Brendon L. / Fletcher, Robert A. / Slee, April / Rapattoni, Wally / Ang, Fernando G. / Arnott, Clare / Levin, Adeera / Verma, Subodh et al. | 2024
- 763
-
Implementing Control‐IQ technology after a virtual educational camp in children and adolescents with type 1 diabetes: Does time in range plateau over 1 year?Scaramuzza, Andrea E. / Marigliano, Marco / Bonfanti, Riccardo / Cherubini, Valentino / Schiaffini, Riccardo / Toni, Sonia / Rabbone, Ivana / The vEC Study Group et al. | 2024
- 767
-
Artemisinin alleviates obesity‐related glomerulopathy by downregulating CYP24A1 expressionChen, Xiaorong / Xiang, Jie / Gao, Peng / Wang, Lijuan / Xiang, Li / Lu, Zongshi / Cao, Tingbing / Mou, Aidi / Zhang, Xingping / Jiang, Xiaoyan et al. | 2024
- 772
-
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open‐label, controlled trialFan, Yujuan / Xia, Mingfeng / Yan, Hongmei / Li, Xiaoying / Chang, Xinxia et al. | 2024
- 777
-
Obesity attenuates acute phosphate excretion after an oral challenge in females: A sex‐specific effect of obesity on phosphate handlingSharma, Jaya K. / Turner, Mandy E. / Paynter, Amanda S. / White, Christine A. / Ward, Emilie C. / Adams, Michael A. / Holden, Rachel M. et al. | 2024
- 782
-
Semaglutide, suicidal ideation and behaviour: A resting state functional magnetic resonance imaging perspectiveVerovnik, Barbara / Vovk, Andrej et al. | 2024
- 785
-
Improvements in post‐challenge lipid response following tirzepatide treatment in patients with type 2 diabetesMather, Kieren J. / Coskun, Tamer / Pratt, Edward J. / Milicevic, Zvonko / Weerakkody, Govinda / Thomas, Melissa K. / Haupt, Axel / Ruotolo, Giacomo et al. | 2024
- 790
-
Correction to Clinical features of generalized lipodystrophy in Turkey: A cohort analysis| 2024
- C1
-
Front CoverFeng, Lingge / Chen, Chunxiang / Guo, Quanle / Chen, Li / Yang, Wenying et al. | 2024